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Summary
Objective: To investigate the relationship between matrix metalloproteinase (MMP) activity and osteochondritis dissecans (OCD) in the
equine joint.
Methods: Equine articular cartilage was obtained from normal (N=8) and osteochondrotic (OCD) (N=6) femoropatellar joints from horses at
necropsy. The activity of gelatinase MMPs was determined in sections of cartilage by in situ gelatin zymography.
Results: Gelatinase activity was markedly increased in articular cartilage obtained from OCD samples and was particularly prominent in the
deep cartilage zone. Activity was only seen in the pericellular area of chondrocytes. In addition, in OCD cartilage there were vertical lines of
activity, starting from the deep zone and radiating towards the articular surface. In contrast, normal cartilage showed only a very small
amount of gelatinolytic activity, which was not restricted to specific cartilage zones. Gelatin zymography of culture supernatants from isolated
chondrocytes demonstrated increased production of MMP-2 and MMP-9 from OCD chondrocytes.
Conclusions: Sections of articular cartilage from OCD lesions revealed MMP activity, especially in the deep zone adjacent to the calcified
subchondral bone. This MMP activity could account for the loss of cartilage integrity in the deep cartilage zone and the vertical lines of
activity could represent areas of mechanical weakness, likely to result in fissures and the release of cartilage fragments into the joint space.
© 2002 OsteoArthritis Research Society International. Published by Elsevier Science Ltd. All rights reserved.
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Osteochondrosis (OC) is an important disorder of cartilage
physiology, characterized by disturbances of endochondral
ossification, which can occur at both the articular surfaces
and growth plates1–3. OC is not specific to man, but is
found in many other mammals including the horse, in which
it is a serious disabling condition, particularly in athletic
animals4. Because of the similarities of naturally occurring
lesions, and because of the difficulty of detection of early
lesions in man, the horse may be considered to be an
appropriate model for the study of OC and provide insights
into its pathogenesis5. Furthermore, OCD is a serious
welfare issue in horse, due to extensive stress on leg joints
during running. As such, it is a common orthopaedic
problem for this species.
One manifestation of OC is osteochondrosis dissecans
(OCD), which is considered to be a failure of cellular
differentiation in growing cartilage resulting in thickening or
retention of growth cartilage, development of fissures and
eventual focal loss of cartilage flaps into the joint cavity.
The resulting fragments can lead to severe joint inflamma-
tion6 and the joint can subsequently develop secondary
osteoarthritis (OA).653The causes of OCD are poorly understood. However,
a number of factors have been implicated in the
horse, including skeletal growth rates, nutrition, genetics,
minerals, physical activity, hormones, toxins and sepsis3,7.
Dyschondroplasia is an early feature of equine OCD8, and
is one of the most common developmental joint disorders
affecting young rapidly growing horses4. This disorder is
characterized by a focal failure of endochondral ossifica-
tion. The primary lesions generally develop in the deep
zone of the cartilage and result in retained non-mineralized
cartilage cores9,10. Since it is probable that these focal
lesions represent areas of abnormal cartilage turnover, it
is not unreasonable to suggest that they may be due to
an imbalance of anabolic and catabolic physiological
processes of chondrocytes.
In recent years, many investigators have focused on
biochemical changes in joint diseases. Many previous
studies have shown an increase in enzymatic degradation
of extracellular matrix, such as collagens and proteo-
glycans in a range of joint diseases, including OA and
rheumatoid arthritis (RA)11–13.
Matrix metalloproteinases (MMPs) are a large expanding
family of neutral zinc dependent endopeptidases involved
in the physiological turnover of extracellular matrix (ECM).
To date, more than 22 MMPs have been identified. They
can degrade all the structural components of cartilage
ECM14,15. They are synthesized and secreted by differ-
ent cell types as latent forms that require extracellular
activation by other proteinases16, including other
MMPs15,17. MMP activities are regulated locally via specific
tissue inhibitor of MMPs (TIMPs) and systemically by
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SAMPLES
Equine articular cartilage was collected from normal
and osteochondrotic joints from the Large Animal
Hospital at the University of Liverpool (Liverpool, U.K.). All
samples were collected post mortem. Normal sampleswere collected from fetlock (N=3; age range 7–26 months)
and femoropatellar joints (N=5; 10 months to 6 years).
None of the normal joints or samples showed any signs of
disease or infection. They were obtained from skeletally
mature horses killed for reasons other than joint disease.
OCD samples were obtained from femoropatellar joints of
five horses with different scales of OCD lesions (aged 5
and 24 months). Full thickness slices of cartilage were
taken parallel to the articular surface of the samples. OCD
samples were taken from the edges of the lesions. Once
taken, cartilage slices were placed quickly on to aluminium
foil, covered with an embedding medium (OTC; Bright
Instruments, U.K.) and snap frozen in liquid nitrogen before
being wrapped in plastic film and stored at −80°C until
required.HISTOLOGY AND TISSUE MANIPULATION
Cartilage samples were each divided into two specimens
and mounted on a cork disc. Before embedding, the tissues
were orientated so that when frozen sections were taken,
they produced serial sections representing two vertical
series through the cartilage (from articular surface to deep
calcified zone) at right angles to each other. Alternate
sections were used for ISZ and hematoxylin and eosin
(H&E) staining.IN SITU ZYMOGRAPHY
Bovine gelatin, tissue culture grade (Sigma, U.K.), was
fluoresceinated using a fluorescein labeling kit (Boehringer
Mannheim Biochemica, U.K.) using the method of Galis
et al.35. Fluorescein isothiocynate-labeled gelatin (1 mg/ml
in PBS) was mixed 1:1 with a solution of 1% low melting
point agarose melted in 50 mM Tris/HCl (pH 7.2) containing
10 mM CaCl2, 0.25% v/v Brij and 0.1% w/v NaN3. The
liquid mixture was kept at 50°C in an incubator for 1 h and
spread evenly on pre-warmed slides using a similar mode
to that used to generate blood smears. The film was then
allowed to set at room temperature and stored in a humidi-
fied chamber at 4°C until use. Prior to use, the films
were examined by fluorescence microscopy to ensure
homogeneous coating of the slide. Serial horizontal and
vertical cryosections of frozen cartilage samples (8 m
thickness) were prepared using a tungsten knife on a
cryostat (Bright Instruments). The sections were placed in
the middle of substrate-coated slides and covered with
15 l of 50 mM Tris buffer, pH 7.4. All sections were sealed
and incubated in a humidified chamber at 37°C for 12–18 h.
To confirm that any lysis was due to MMP activity, some
sections were treated with 10 mM EDTA to inhibit MMP
activity. The slides were visualized under a fluorescence
microscope (Leitz Vario Orthomat 2) and photographs
taken of the sections. Enzymatic activity was manifested as
relatively dark areas against a bright green field.
The level of total gelatinase activity in each field of an
OCD cartilage section viewed was determined using the
LSM 510 software (Zeiss) to measure the integrated area
of fluorescence intensity obtained. The mean and standard
deviation of gelatinolytic activity of chondrocytes in different
cartilage zones was determined. Six sections of OCD
cartilage were analysed in this way. Eight fields per each
cartilage zone (superficial, upper mid, lower mid and deep)
were quantified, representing an area occupied by between
70 and 100 chondrocytes per zone in total for each section.
The data were expressed as mean±S.D.2-macroglobulin18,19. MMPs are classified into four main
groups according to their substrate specificity: the colla-
genases (MMP-1, -8 and -13) cleave interstitial collagen
triple helices; gelatinases (MMP-2 and -9) act mainly on
unwound collagen and gelatin; the stromelysins (MMP-3,
-10 and -11) are able to degrade proteoglycans, collagen
types II, IX, XI, and participate in the activation of pro
MMP-1, -8, -9 and -13; the membrane-type MMPs (MT-
MMPs), such as MMP-14, -15, -16 and -17, are able to
activate other pro MMPs20,21.
MMP-2 and MMP-9, also termed gelatinases A and B
respectively, can degrade type IV collagen of basement
membranes, collagen types V, VII, and X as well as
denatured collagen (gelatin), fibronectin, laminin, elastin,
and proteoglygans22. ProMMP-2 is activated on the cell
surface by MT1-MMP21, whereas many other enzymes
can activate MMP-923. MMP-2 and 9 are inhibited by
2-macroglobulin and the specific inhibitors of metallo-
proteinases, TIMP-2 and TIMP-1.
MMPs have been considered to play a major role in
cartilage degradation in all forms of arthritis15,24,25.
Increased production of several MMPs has been demon-
strated in RA joints17,26,27, as well as in OA cartilage28–30.
However, very little work has been reported concerning
MMP activity in OC and OCD. Clegg et al.31 using gelatin
zymography, found increased activities of MMP-2 and -9 in
the synovial fluids of horses with OCD. In addition, elevated
serine proteases were found in OCD articular cartilage32
while MMP levels have been shown to be increased in
copper deficient horses with clinical lesions of OC33.
Stromelysin activities were also demonstrated in synovial
fluids in horses affected with OCD using a fluorometric
assay34. It is important to clarify what role, if any, MMPs
have in the pathogenesis of OCD and to determine their
sites of activity in OCD cartilage.
Although the localization of particular metalloproteinases
in tissue may be determined using immunohistochemistry
techniques, such approaches are limited in their useful-
ness. Immunohistochemistry does not generally provide
accurate information about the activation status of
enzymes. This would be best achieved by analysis of
metalloproteinases within the cartilage matrix using tech-
niques able to specifically detect active enzymes. One such
technique is in situ zymography (ISZ), in which a fluor-
esceinated enzyme substrate is placed in close contact
with a cryostat section of unfixed tissue. Lysis of the
substrate demonstrates the presence of active enzymes
and localizes the site of enzyme activity in the tissue. Lysis
is visualized as dark zones in otherwise brightly fluorescent
substrate films35.
In the present study we have used ISZ (supported by
gelatin zymography) to investigate gelatinase-degrading
MMP activities in normal and OCD equine articular carti-
lage. The results showed a dramatic localized increase in
gelatinase activity around chondrocytes in the deep zone of
OCD cartilage. Our results suggest that chondrocytes may
be central to the pathology of equine OCD.
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Full-thickness cartilage was obtained from clinically
normal and OCD femeropatellar joints. Cartilage was
removed aseptically into Dulbecco’s modification of Eagle’s
medium (DMEM) containing sodium pyruvate and 1 g/l
glucose. Penicillin (100 U/ml), streptomycin (100 g/ml)
and amphotericin B (2.5 g/ml) were included. Tissue
culture reagents were from Gibco (Paisley, Scotland, U.K.)
Chondrocytes were isolated by overnight digestion of
cartilage at 37°C with gentle agitation, in serum-free DMEM
containing 0.1% w/v bacterial collagenase (Gibco, U.K.).
Released chondrocytes were filtered through a 40 m
mesh, pelleted at 250×g, washed four times in 0.1 M NaCl,
then resuspended in a 1.2% w/v solution of sodium alginate
(low viscosity; Sigma) in 0.15 M NaCl at a concentration of
about 3×106 cells/ml. Beads were formed by dropping the
suspension through a 12 gauge needle into 0.1 M CaCl2 as
previously described36. The beads were washed three
times in 0.15 M NaCl and once with medium. Cultures were
maintained at 37°C in 5% CO2-in-air, with replacement of
medium containing 10% FCS, every 2 or 3 days.GELATIN ZYMOGRAPHY
Sodium dodecyl sulphate-polyacrylamide gel electro-
phoresis (SDS-PAGE) was performed using a vertical
gel apparatus (Miniprotean II system, Biorad)37. Gelatin
was co-polymerized into 0.75 mm thick, 7.5% polyacryl-
amide gels at a final concentration of 2.5 mg/ml. Cell
culture supernatant samples were diluted 1:1 in a Tris/HCl
sample buffer containing 1.5% SDS, 5% glycerol and
0.005% Bromophenol blue, pH 6.8 and incubated at 37°C
for 1 h prior to electrophoresis. Samples (10 l) were
electrophoresed at 200 V for approximately 45 min. Follow-
ing electrophoresis, the gels were washed for 1 h at room
temperature in 2.5% Triton X-100, rinsed thoroughly in
distilled water and incubated for 18 h at 37°C in a reacti-
vation buffer containing 50 mMTris/HCl, 50 mM CaCl2,
10 mM NaCl, 0.05% Brij35, pH 7.6. Following incubation,
gels were stained with 0.2% Coomassie brilliant blue R-250
in 10% acetic acid followed by destaining in a mixture of 7%
(v/v) glacial acetic acid, 30% (v/v) methanol and 63% (v/v)
distilled water until clear bands over a dark background
were observed. Gels were scanned, images stored in a
computer and band intensities calculated by use of NIH
Image (v 1.62).ResultsNORMAL CARTILAGE SHOWS LOW LEVELS OF GELATINOLYTIC
ACTIVITY
Sections from six of eight normal horse articular cartilage
samples (aged 10 months to 6 years) did not produce lysis
of fluoresceinated gelatin [Fig. 1(a)]. This was a consistent
finding throughout all articular cartilage zones from the
articular surface to the deep layer. Sections from two
normal young horses, aged 7 and 12 months, revealed
weak gelatinolytic activity that appeared as small dark
zones around chondrocytes, mainly in the middle zone of
the articular cartilage [Fig. 1(b)]. No obvious differences
were seen between normal fetlock and femoropatellar
cartilage samples (data not shown).GELATINASE ACTIVITY IS HIGH IN OCD CARTILAGE
In OCD cartilage (obtained from femoropatellar joints),
there was clear loss of gelatin substrate, indicating high
levels of gelatinolytic activity [Fig. 1(c)]. Some OCD carti-
lage was sectioned and stained with hematoxylin and eosin
for structural comparisons and to ensure correct orienta-
tion. The sections showed the orientation of full thickness
articular cartilage. In the deep zone of OCD cartilage, cells
aggregated in clusters of varying size, containing between
two and five chondrocytes within each cartilage lacuna
[Fig. 2(a)]. These chondrocyte clusters were seen only in
the deep zone. Analysis of this area by ISZ showed enzyme
activity primarily around these clusters and close to the
calcified zone [Fig. 2(b)].Fig. 1. ISZ sections from (a) normal adult articular cartilage, (b)
cartilage from a young normal horse and (c) adult OCD cartilage
(25×).GELATINASE ACTIVITY IS CONCENTRATED IN THE DEEP ZONE OF
OCD CARTILAGE
Serial horizontal sections were taken throughout all
articular cartilage zones including the calcified tissues. The
gelatinolytic activity was seen predominantly in the deep
656 F. Al-Hizab et al.: Gelatinase activity in OCD cartilageFig. 2. Sections representing distribution of gelatinase activity in OCD cartilage. (a) Hematoxylin and eosin staining, showing chondrocyte
clustering (black arrow) and calcification (Ca), in the deep calcified zones. (b) ISZ, of the deep and calcified zones, showing enzymatic
activity in the extracellular matrix (white arrow), mainly around the chondrocytes (black arrows). Autofluorescence was seen in the calcified
areas (Ca). (c) ISZ showing high enzymatic activity (white arrows) in the deep zone (DZ) and relatively little in lower middle zone (LMZ). (d)
ISZ showing low enzymatic activity (white arrows) in the middle zone (Mid) and occasional activity in the superficial zone (Sup); this was only
rarely seen (white arrow).articular cartilage zone [Fig. 2(c)]. This activity, demon-
strated primarily around chondrocytes, extended out
slightly into the extracellular matrix [Fig. 2(b)]. In particular,
the activity was observed close to the calcified part of the
cartilage but with variable gelatinolytic activity between
individual chondrocytes. In addition, scattered, focal enzy-
matic activity was detected around chondrocytes in the
middle zone [Fig. 2(c), (d)], while enzymatic activity was
rarely observed in the superficial zone [Fig. 3(d)]. Some
scattered areas of gelatinase activities also protruded from
the deep zone where most areas of digestion were
observed [Fig. 3(d)], through the middle zone [Fig. 3(b), (c)]
to the lower superficial zone [Fig. 3(a)] as a line roughlyperpendicular to the articular surface [Fig. 3(e)]. This
unusual pattern was, as in the deep zone, associated with
chondrocytes and their immediate ECM environment. This
pattern of activity was not seen in any normal articular
cartilage. These data are represented diagrammatically
(Fig. 4). The quantitative analysis of the enzymatic activity
around chondrocytes in different cartilage zones in OCD
cartilage (Fig. 5) supported the histological observations
and showed that the activity in the deep zone was 5 times
greater than that in the upper middle and superficial zones.
Control sections incubated with standard buffer containing
10 mM EDTA (MMP inhibitor) showed minimal digestion of
the substrate after 18 hours (data not shown).
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BEADS IS MARKEDLY INCREASE IN OCD CHONDROCYTES
There was an increase in the release of gelatinases,
particularly (pro-) MMP-2 at 64 KDa, from chondrocytealginate beads into the culture medium in each of the two
OCD samples. Compared with the normal samples, in
which only relatively little (pro-) MMP-2 was released, OCD
samples revealed an increased release of MMP-2 and a
small amount of (pro-) MMP-9 release (Fig. 6). There was
no noticeable MMP-9 release from normal control cartilage.
MMP-9 levels were also increased in the joint contralateral
to that showing clinical signs of OCD, even through this
contralateral joint showed no cartilage damage and
appeared normal.Fig. 3. ISZ: horizontal sequential sections of OCD cartilage. These
range from superficial (a) to the upper (b) and lower (c) middle
zone and (d) the deep zone. These show strong enzymatic activity
(white arrows) throughout the deep zone and discrete projection
into the mid zone and superficial zone. Ca=Calcified region
(autofluorescence). (e) ISZ of vertical section of OCD cartilage,
showing lines of gelatinase activity in the middle zone.Fig. 4. Three-dimension representation of OCD cartilage, showing
gelatinolytic activity (dark areas) in much of the deep zone (d) and
as vertical lines, protruding from the deep (d) zone through the
lower (c) and upper (b) middle zones towards the superficial zone
(a). Plane of sections shown in Fig. 3 are indicated (a, b, c, d).Discussion
MMPs are secreted as inactive zymogens, which require
activation, by cleavage of a propeptide, for conversion
into mature enzymes. Furthermore, they are often com-
plexed with protein inhibitors (including TIMPs and -2
macroglobulin), that regulate their activity. ISZ was used
to assess the net functional activity of MMPs in OCD
cartilage, since this technique can distinguish between
activated and inactivated (either zymogen or inhibitor-
complexed) forms of these enzymes. By comparison,
other tissue localization methods, such as immunohisto-
chemistry, are unable to distinguish between the activated
and inactivated forms of MMPs. In addition, ISZ enables
identification of the sites of enzymatic activity within the
cartilage.
Development of articular cartilage is a stepwise process,
each involving different cellular processes (migration,
adhesion, proliferation, growth) and each subject to differ-
ent physiological and genetic controls. Any defect in any
step could alter the growth of articular cartilage leading to a
disorder. OCD is frequently described as a disease with
658 F. Al-Hizab et al.: Gelatinase activity in OCD cartilageFig. 5. Quantification of gelatinolytic activity around chondrocytes in different zones in OCD cartilage. The zones of cartilage were analysed
as described in the methods.multifactorial causes related to growth, such as poor blood
supply of cartilage38–40. It has been proposed that in OCD,
the whole subarticular growth cartilage is mechanically
weak and thus susceptible to mechanical failure41. Mech-
anical stimulation of chondrocytes through cell-matrix inter-
actions is well established to alter synthesis of many matrix
components42–44. Alterations in the mechanical stability
and matrix integrity in OCD cartilage could alter such
processes and may explain changes in the distribution of
matrix enzymes and components in OCD cartilage. There-
fore, increased enzyme expression in specific cartilage
zones might play a key role in initiating and developing the
lesions seen in OCD. Abnormal expression of degradative
enzymes (including MMPs) has been hypothesized to play
a role in the pathogenesis of OCD7,41,44. Specifically,
up-regulated production of MMP-2 and MMP-9 has been
demonstrated in cartilage, in an experimental copper-
deficiency model of equine OC33, as well as in synovial
fluids from joints of horses with naturally occurring OCD45.
Clegg et al.31 found increased gelatinase activity and
Brama et al. found increased stromelysin activities in
equine OC synovial fluids34,46. However, increased pro-
tease levels in synovial fluid may not accurately reflect
activities in the cartilage itself and there are a few studies
examining protease levels in OCD cartilage, showing
only cathepsin B activity32. To date, no data have been
published on gelatinase activities in OCD cartilage.
In this study we have shown, using ISZ, increased
gelatinolytic activity in equine OCD cartilage, compared
with that found in normal cartilage. The low levels of
gelatinolytic activity observed in adult cartilage are perhaps
unsurprising, since it is well established that normal adult
articular cartilage has a highly stable matrix with a very low
level of matrix component turnover47. In some youngnormal horses, the low levels of gelatinase activity seen
around chondrocytes throughout the cartilage, may be due
to background physiological matrix turnover in the growing
horse. The increased levels of gelatinolytic activity in OCD
articular cartilage were mainly demonstrated in the deep
zone. This activity was localized around clusters of
chondrocytes, which may indicate unusual hyperactivity of
the cells in this zone. Although, most gelatinolytic activity
was demonstrated in the deep zone, there was variable
activity between individual chondrons, which may either be
due to real differences in gelatinase levels or a conse-
quence of closer proximity of pericellular gelatinases to the
fluoresceinated gelatin coat. In addition to this pattern of
gelatinase activity, there was some focal enzymatic activity
protruding toward the surface as lines of chondrocytes, with
the activity reducing towards the cartilage surface. It is not
certain if these areas of enzymatic activity relate to the
cartilage canals. The significance of these vertical areas is
unknown. However, they may indicate potentially vulner-
able areas in the matrix, where OCD cartilage may later
break down so that cartilage flaps are formed. There are a
number of studies that have suggested that poor healing of
early articular cartilage canals is one of the main causes of
OCD41, and the vertical lines of enzymatic activity shown in
OCD may be at the sites of pre-existing old cartilage
canals. Alternatively, another possibility may be that the
gelatinase activity represents a manifestation of attempted
wound healing in OCD.
The identity of the specific protease or proteases
involved is not known. Gelatin is a favourite substrate for
gelatinases (MMP-2 and MMP-9), although MMP-3 and
MMP-1 are also known to have a weak action in digesting
gelatin18 and the cysteine protease cathepsins22 will also
digest this substrate. However, incubation of the sections
Osteoarthritis and Cartilage Vol. 10, No. 8 659with EDTA, an inhibitor of MMP activity, prevented gelatin
lysis (data not shown), suggesting that substrate degrada-
tion was mainly due to matrix metalloproteinase activity.
This is supported by the gelatin zymography of super-
natants from cultured chondrocytes which clearly demon-
strated that MMP-2 and MMP-9 release is increased in
OCD chondrocytes.
The demonstration of increased gelatinolytic activity and
MMP-2 and -9 productions in OCD cartilage is not proof
that gelatinases are directly responsible for loss of cartilage
integrity in OCD lesions. Gelatinase production could
coincide with production of other degradative proteases, for
example collagenases. Additionally, it is possible that the
high levels of gelatinolytic activity may be balanced by
production of new matrix components and represents one
side of a dramatically increased level of tissue turnover,
perhaps in response to rapid remodeling. We did not
examine anabolic activities in the present study and this
area merits further study.
Our work clearly demonstrates involvement of gelatino-
lytic activity in the physiology of OCD cartilage and
indicates a differential response of chondrocytes in different
cartilage zones. However, we have no knowledge at
present about the signals that control production of such
enzymes. Future work, using OCD cartilage explants
exposed to a range of chemical and physical stimuli, maylead to a greater understanding of the disease mechanisms
in OCD. Such knowledge will lead to the possibility of
rational therapeutic intervention in this disorder.Acknowledgments
Financial support was provided by King Faisal University,
College of Veterinary Sciences, Saudi Arabia and by
the Home of Rest for Horses, U.K. We would like to
acknowledge Dr David Spiller, Biological Sciences,
University of Liverpool, for imaging assistance.Fig. 6. Gelatin zymography of OCD and normal chondrocytes cultured in alginate beads: (a) Gelatin zymography, (b) Quantitation of
pro-MMP-2 and MMP-9 on zymography gel. Normal 1=cartilage from a horse without joint lesions; OCD 1 and OCD 2=cartilage from two
horses with OCD in femoropatellar joints; Normal 2=cartilage from the normal, healthy, contralateral joint to the affected OCD 2 joint; Normal
3=cartilage from an unrelated, apparently normal joint (fetlock) from OCD 2 horse.References
1. Stanescu V, Stanescu R, Maroteaux P. Pathogenic
mechanisms in osteochondrodysplasias. J Bone
Joint Surg Am 1984;66:817–36.
2. Pappas AM. Osteochondrosis dissecans. Clin Orthop
1981;158:59–69.
3. Hurtig MB, Pool RR. Pathogenesis of equine osteo-
chondrosis. In: McIlwraith CW, Trotter GW, Eds. Joint
Disease in the Horse. Philadelphia: Saunders 1996:
335–58.
660 F. Al-Hizab et al.: Gelatinase activity in OCD cartilage4. Jeffcott LB. Problems and pointers in equine osteo-
chondrosis. Equine Vet J Suppl 1993;16:1–3.
5. Olsson SE. Osteochondrosis in domestic animals.
Introduction. Acta Radiol Suppl 1978;358:9–14.
6. McIlwraith CW, Nixon AJ. Joint resurfacing: attempts at
repairing articular cartilage defects. In: McIlwraith
CW, Trotter GW, Eds. Joint Disease in the Horse.
Philadelphia: WB Saunders 1996:317–34.
7. Jeffcott LB. Osteochhondrosis in horse-searching the
key to pathogenesis. Equine Vet J 1991;23:331–8.
8. Lillich JD, Bertone AL, Malemud CJ, Weisbrode SE,
Ruggles AJ, Stevenson S. Biochemical, histochemi-
cal, and immunohistochemical characterization of
distal tibial osteochondrosis in horses. Am J Vet Res
1997;58:89–98.
9. Savage CJ, McCarthy RN, Jeffcott LB. Effect of dietary
energy and protein in induction of dyschondroplasia
in foals. Equine Vet J Suppl 1993;16:74–9.
10. Henson FM, Davies ME, Jeffcott LB. Equine dyschon-
droplasia (osteochondrosis)-histological findings and
type VI collagen localization. Vet J 1997;154:53–62.
11. Harris ED, Parker HG, Radin EL, Krane SM. Effects of
proteolytic enzymes on structural and mechanical
properties of cartilage. Arthritis Rheum 1972;15:
497–503.
12. Hibbs M, Hoidal J, Kang A. Expression of a metallo-
proteinase that degrades native type V collagen and
denatured collagens by cultured human alveolar
macrophages. J Clin Invest 1987;80:1644–50.
13. Malemud CJ, Martel-Pelletier J, Pelletier JP. Degrada-
tion of extracellular matrix in osteoarthritis: 4 funda-
mental questions. J Rheumatol 1987;14:20–22.
14. Borkakoti N. Matrix metalloproteinases: variations on a
theme. Prog Biophys Mol Biol 1998;70:73–94.
15. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor
LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix
metalloproteinases: a review. Crit Rev Oral Biol Med
1993;4:197–250.
16. Fang K, Raymond WW, Lazarus S, Caughey G. Dog
mastocytoma cells secrete a 92-kD gelatinase acti-
vated extracellularly by mast cell chymase. J Clin
Invest 1996;97:1589–96.
17. Ishiguro N, Ito T, Obata K, Fujimoto N, Iwata H.
Determination of stromelysin-1, 72 and 92 kDa
type IV collagenase, tissue inhibitor of
metalloproteinase-1 (TIMP-1), and TIMP-2 in syno-
vial fluid and serum from patients with rheumatoid
arthritis. J Rheumatol 1996;23:1599–604.
18. Murphy G. Matrix metalloproteinases and their inhibi-
tors. Acta Orthop Scand Suppl 1995;266:55–60.
19. Cawston TE. Metalloproteinase inhibitors and the pre-
vention of connective tissue breakdown. Pharmacol
Ther 1996;3:163–82.
20. d’Ortho MP, Will H, Atkinson S, Butler G, Messent A,
Gavrilovic J. Membrane-type matrix metallo-
proteinases 1 and 2 exhibit broad-spectrum
proteolytic capacities comparable to many matrix
metalloproteinases. Eur J Biochem 1997;250:751–7.
21. Kinoh H, Sato H, Tsunezuka Y, Takino T, Kawashima A,
Okada Y. MT-MMP, the cell surface activator of
proMMP-2 (pro-gelatinase A), is expressed with its
substrate in mouse tissue during embryogenesis.
J Cell Sci 1996;109:953–9.
22. Werb Z, Alexander CM. Proteolytic enzymes. In: Kelly
WN, Harris ED, Ruddy S, Sledge CB, Eds. Textbook
of Rheumatology. Philadelphia: WB Saunders
1993:248–68.23. Murphy G, Cockett M, Stephens P, Smith B, Docherty
AJ. Stromelysin is an activator of procollagenase.
Biochem J 1987;248:265–68.
24. Partsch G, Matucci-Cerinic M, Marabini S, Jantsch S,
Pignone A, Cagnoni M. Collagenase synthesis of
rheumatoid arthritis synoviocytes: dose-dependent
stimulation by substance P and capsaicin. Scand J
Rheumatol 1991;20:98–103.
25. Woessner JF. Matrix metalloproteinases and their
inhibitors in connective tissue remodeling. FASEB J
1991;5:2145–54.
26. Walakovits LA, Moore VL, Bhardwaj N, Gallick GS,
Lark MW. Detection of stromelysin and collagenase
in synovial fluid from patients with rheumatoid
arthritis and posttraumatic knee injury. Arthritis
Rheum 1992;35:35–42.
27. Posthumus MD, Limburg PC, Westra J, Cats HA,
Stewart RE, van Leeuwen MA, et al. Serum levels of
matrix metalloproteinase-3 in relation to the develop-
ment of radiological damage in patients with early
rheumatoid arthritis. Rheumatology 1999;38:1081–7.
28. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS,
Woessner JF. Evidence for metalloproteinase and
metalloproteinase inhibitor imbalance in human
osteoarthritic cartilage. J Clin Invest 1989;84:678–85.
29. Mehraban F, Lark MW, Ahmed FN, Xu F, Moskowitz
RW. Increased secretion and activity of matrix
metalloproteinase-3 in synovial tissues and chondro-
cytes from experimental osteoarthritis. Osteoarthritis
Cart 1998;6:286–94.
30. Sasaki S, Iwata H, Ishiguro N, Obata K, Miura T.
Detection of stromelysin in synovial fluid and
serum from patients with rheumatoid arthritis and
osteoarthritis. Clin Rheumatol 1994;13:228–33.
31. Clegg PD, Burke RM, Coughlan AR, Riggs CM,
Carter SD. Characterisation of metalloproteinases 2
and 9: and identification of the cellular sources of
these enzymes in joints. Equine Vet J 1997;29:
335–42.
32. Hernandez-vidal G, Jeffcott LB, Davies M. Immuno-
localization of cathepsin B in equine dyschondro-
plastic articular cartilage. Vet J 1998;15:193–201.
33. Hurtig M, Green SL, Dobson H, Mikuni-Takagaki Y,
Choi J. Correlative study of defective cartilage and
bone growth in foals fed a low copper diet. Equine
Vet J suppl 1993;16:66–73.
34. Brama P, TeKoppele J, Beekman B, van El B,
Barneveld A, van Weeren P. Influence of develop-
ment and joint pathology on stromelysin enzyme
activity in equine synovial fluid. Ann Rheum Dis
2000;59:155–57.
35. Galis ZS, Sukhova GK, Libby P. Microscopic localis-
ation of active proteases by in-situ zymography:
Detection of matrix metalloproteinase activity in
vascular tissue. FASEB J 1995;9:974–980.
36. Guo JF, Jourdian G, MacCallum DK. Culture and
growth characteristics of chondrocytes encapsulated
in alginate beads. Connect Tissue Res 1989;19:
277–97.
37. Clegg PD, Burke RM, Coughlan AR, Riggs CM, Carter
SD. Matrix metalloproteinases 2 and 9 in equine
synovial fluids. Equine Vet J 1997;29:343–8.
38. Hibbs MS, Hasty KA, Seyer JM, Kang AH, Mainardi
CL. Biochemical and immunological characterization
of the secreted forms of human neutrophil gelatinase.
J Biol Chem 1985;260:2493–500.
Osteoarthritis and Cartilage Vol. 10, No. 8 66139. Carlson CS, Hilley HD, Meuten DJ. Degeneration of
cartilage canal vessels associated with lesion of
osteochondrosis in swine. Vet Pathol 1989;26:47–54.
40. Carlson CS, Meuten DJ, Richardson DC. Ischemic
necrosis of cartilage in spontaneous and experimen-
tal lesions of osteochondrosis. J Orthop Res
1991;9:317–329.
41. Ekman S, Carlson CS. The pathophysiology of osteo-
chondrosis. Vet Clin North Am Small Anim Pract
1998;28:17–32.
42. Nakano T, Aherne FX. The pathogenesis of
osteochondrosis—a hypothesis. Med Hypotheses
1994;43:1–5.
43. Saamanen AM, Tammi M, Kiviranta I, Helminen HJ.
Running exercise as a modulatory of proteoglycan
matrix in the articular cartilage of young rabbits. Int J
Sports 1988;2:127–33.44. Kiviranta I, Tammi M, Jurvelin J, Arkokoski J,
Saamanen AM, Helminen HJ. Articular cartilage
thickness and glycosaminoglycan distribution in the
canine knee joint after strenuous running exercise.
Clin Orthrop 1992;283:302–8.
45. Jeffcott LB, Henson FMD. Studies on growth cartilage
in the horse and their application to aetiopatho-
genesis of dyschondroplasia (osteochondrosis). Vet
J 1998;156:177–92.
46. Brama P, TeKoppele J, Beekman B, van Weeren P,
Barneveld A. Matrix metalloproteinase activity in
equine synovial fluid: influence of age, osteoarthritis,
osteochondrosis. Ann Rheum Dis 1998;57:697–9.
47. Lippiello L, Hall D, Mankin H. Collagen synthesis in
normal and osteoarthritic human cartilage. J Clin
Invest 1977;59:593–600.
